All News

Global Plasma Fractionation Market: Size & Trends Shows a Rapid Growth by 2027

Global Plasma Fractionation Market– Industry Trends and Forecast to 2028” Worldwide Industry Size, Offer and trends analysis during Period. The report is a thoughtful analysis of the market presenting the propelled situation in the market and additionally plots that guide in its expansion in the coming years. The Global Plasma Fractionation Market report assesses a few elements are deciding the market development and additionally the volume of the entire Industry. The statement expresses the vendor’s landscape of the market together with the profiles of the leading market players. The most significant players in the Market are likewise discussed in the report.

Global Plasma Fractionation Market Report contains key drivers and Restraints of the market with their information and market competition situation among the vendors and company profile. Product picture, specification, classification, category are also mentioned. Comprehensively evaluates absolute scrutiny of the competitive landscape, covering value chain and key players.

Global Plasma Fractionation Market By Product (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Other Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Other Applications), End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Plasma Fractionation Market

Global plasma fractionation market is registering a substantial CAGR of 7.10% in the forecast period of 2019-2026. This rise in the market can be attributed to the surging incidence of respiratory disease and increasing aging population.

Download FREE Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this [email protected]

Competitive Analysis:

Global plasma fractionation market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of plasma fractionation market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major market competitors currently working in the global plasma fractionation market are CSL Plasma, Grifols, S.A., Shire, Octapharma, Kedrion S.p.A, BPL Inc., Sanquin, Biotest AG, LFB S.A., Japan Blood Products Organization, China Biologic Products Holdings, Inc., GREEN CROSS CORP, Shanghai RAAS, Baxter, Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Novasep Inc., Pall Corporation, Merck KGaA and Boccard among others.

Market Definition: Global Plasma Fractionation Market

Plasma fractionation is a method of dividing different plasma parts. It is used to protect and treat life-threatening illnesses triggered by trauma, immunological illnesses, and infections. Plasma fractionation method is used in healthcare applications to treat protein deficiency. It is also used for industrial applications in the manufacturing of packaging material. A primary role of plasma fractionation is the removal or inactivation of viruses and prions.

Market Drivers

  • Surging incidence of respiratory diseases is driving the growth of the market
  • Increasing investment in research and development is helping the market to grow
  • Various government initiatives is flourishing the growth of the market
  • Increasing aging population drives the growth of the market

Market Restraints

  • High cost of plasma products hinders the growth of the market
  • Strict regulations of government restrict the growth of the market
  • Increasing substitutes of plasma products hampers the growth of the market

Key Developments in the Market:

  • In January 2019, Takeda Pharmaceutical Company Limited acquired Shire plc. After this purchase, Takeda is planning to expand its footprint all over the globe. It has done huge investment on R&D committed to Plasma-Derived Therapies and Vaccines which will bring advancement in this field.
  • In August 2018, Grifols, S.A. has announced the completion of the acquisition of Biotest U.S. This deal includes various corporate offices, approx. 900 employees and plasma collection facilities. This purchase will help in expansion of the company.

For More Insights Get FREE Detailed TOC @

Reasons to Purchase this Report

  • Current and future of global plasma fractionation market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Read More @

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.



Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @ [email protected]